The launch of a new immunity ingredient
07 Aug 2017 | Ganeden
Ganeden has used its patented probiotic strain to develop an immune health ingredient: Staimune. The new ingredient utilizes the cells of the probiotic GanedenBC30 to support immune health, at cost effective inclusion levels. Ganeden anticipates Staimune to be an industry changing development. Officially identified as “Inactivated Bacillus coagulans GBI-30, 6086,” Staimune’s ease of formulation opens up new opportunities in functional foods and beverages – most importantly in shelf-stable beverages and high-water-activity products.
Upcoming webinars
Adapting Appetites - Scientific and Industry Perspectives on the Rise of GLP-1 Medications
Kerry Health and Nutrition Institute
Register now
Probiotic Innovation in Menopause: Expert Perspectives and Clinical Evidence
AB-BIOTICS Kaneka Probiotics
Register now
Upliving with Postbiotics: Discover the power of LAC-Living+ in Mood
Morinaga Milk Industry Co., Ltd.
Register now
